Testimony from Prostate Cancer
Patients and Partners

Joel Nowak

Jim Waldenfels

Edward Grove

Richard Gillespie

Alvin Chin

Jan Manarite

Letter: Thomas Farrington

Medical Witnesses

Christopher Logothetis M. D.

Dr. Ke Liu, MD, Ph.D.

Medical Officer, Division of Clinical Evaluation, Pharmacology and Toxicology, CBER, FDA

Dr. Bo-Guang Zhen, Ph.D.

Division of Biostatistics, FDA

Complete Record of FDA Meeting, .pdf

News reports and releases and about Provenge
and other vaccines

Letters to the FDA about Dendreon's application following the Advisory Committee Vote:

Biostatistician Thomas Fleming Urges FDA Against Approval Of Provenge Prostate Cancer Vaccine

Raise A Voice Writes to FDA Advisory Committee